David Paul Fredrickson - 26 Feb 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Reporting relationship: Director
Issuer ticker: CAI
Reported as of: 26 Feb 2026
Net transaction value: +$49,990
SEC form: 4
Accepted by SEC: 27 Feb 2026, 18:08:53 UTC
Prior SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ J. Russel Denton, Attorney-in-Fact

Key filing fact

David Paul Fredrickson filed Form 4 for Caris Life Sciences, Inc. (CAI) on 27 Feb 2026.

Key facts

This page summarizes David Paul Fredrickson's Form 4 filing for Caris Life Sciences, Inc. (CAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Feb 2026, 18:08.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: +$49,990.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002071948 Primary reporting owner

Fredrickson David Paul

Relationship: Director
Address: C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature: /s/ J. Russel Denton, Attorney-in-Fact
Signature date: 27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Common Stock

Award

Transaction value: $49,990
Shares: +2,492
Change %: +15%
Price: $20.06
Shares after: 18,621
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.